The role of single nucleotide polymorphisms (SNPs) in understanding complex disorders and pharmacogenomics

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 3, 2000, Pages 376-382

  Kao, S L ^c   Chong, S S ^a   Lee, Caroline G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c National University of Singapore ^*

Author keywords

Complex diseases; Drug response; Gene discovery; Pharmacogenetics; Single nucleotide polymorphism

Indexed keywords

GLYCOPROTEIN P;

GENETIC LINKAGE; GENETICS; GENOME; HUMAN; PHARMACOGENETICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0034185428     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Collins F S, Brooks L D, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998; 8:1229-31.
2. Li W H, Sadler L A. Low nucleotide diversity in man. Genetics 1991; 129:513-23.
3. Fullerton S M, Harding R M, Boyce A J, Clegg J B. Molecular and population genetic analysis of allelic sequence diversity at the human beta-globin locus. Proc Natl Acad Sci U S A 1994; 91:1805-9.
4. Clark A G, Weiss K M, Nickerson D A, Taylor S L, Buchanan A, Stengard J, et al. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet 1998; 63:595-612.
5. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-8.
6. Marshall E. Drug firms to create public database of genetic mutations. Science 1999; 284:406-7.
7. Kwok P Y, Gu Z. Single nucleotide polymorphism libraries: why and how are we building them? Mol Med Today 1999; 5:538-43.
8. Brookes A J. The essence of SNPs. Gene 1999; 234:1771-86.
9. Lewin B. Isolating the gene. In: Lewin B, editor. Genes VI. Chap 6. New York: Oxford Univ Press, 1997:123.
10. Nebert D W. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 1997; 60:265-71.
11. Wang D G, Fan J B, Siao C J, Berno A, Young P, Sapolsky R, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280:1077-82.
12. Nachman M W, Bauer V L, Crowell S L. Aquadro C F. DNA variability and recombination rates at X-linked loci in humans. Genetics 1998; 150:1133-41.
13. Guillaudeux T, Janer M, Wong G K, Spies T, Geraghty D E. The complete genomic sequence of 424,015 bp at the centromeric end of the HLA class I region: gene content and polymorphism. Proc Natl Acad Sci USA 1998: 95:9494-9.
14. Nebert D W. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Clin Genet 1999; 56:247-58.
15. van Holst Pellekaan S, Frommer M, Sved J, Boettcher B. Mitochondrial control-region sequence variation in aboriginal Australians. Am J Hum Genet 1998; 62:435-49.
16. Zietkiewicz E, Yotova V, Jarnik M, Korab-Laskowska M, Kidd K K, Modiano D, et al. Nuclear DNA diversity in worldwide distributed human populations. Gene 1997; 205:161-71.
17. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516-7.
18. Taillon-Miller P, Piernot E E, Kwok P Y. Efficient approach to unique single-nucleotide polymorphism discovery. Genome Res 1999; 9:499-505.
19. Landegren U, Nilsson M, Kwok P Y. Reading bits of genetic information: methods for single-nucleotide polymorphism analysis. Genome Res 1998; 8:769-76.
20. Ames B N. Cancer prevention and diet: help from single nucleotide polymorphisms. Proc Natl Acad Sci U S A 1999; 96:12216-8.
21. Halushka M K, Fan J B, Bentley K, Hsie L, Shen N, Weder A, et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 1999; 22:239-47.
22. Ferrell R E, Conte V, Lawrence E C, Roth S M, Hagberg J M, Hurley B F. Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 1999; 62:203-7.
23. Keightley A M, Lam Y M, Brady J N, Cameron C L, Lillicrap D. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF: Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999; 93:4277-83.
24. Lee C G, Gottesman M M, Cardarelli C O, Ramachandra M, Jeang K T, Ambudkar S V, et al. HIV-1 protease inhibitors are substrates for the MDR 1 multidrug transporter. Biochemistry 1998; 37:3594-601.
25. Lee C G, Gottesman M M. HIV-1 protease inhibitors and the MDR 1 multidrug transporter. J Clin Invest 1998; 101:287-8.
26. Cordon-Cardo C, O'Brien J P, Casals D, Rittman-Grauer L, Biedler J, Melamed M R, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells al blood-brain barrier sites. Proc Natl Acad Sci U S A 1989; 86:695-8.
27. Cordon-Cardo C, O'Brien J P, Boccia J, Casals D, Bertino J R, Melamed M R. Expression of the multidrug resistance gene product (Pglycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38:1277-87.
28. Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localisation in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 1989; 37:159-64.
29. Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I. Willingham M C. Cellular localisation of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987; 84:7735-8.
30. Chaudhary P M, Roninson I B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991 : 66:85-94.
31. Schinkel A H, Wagenaar E, Mol C A, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996; 97: 2517-24.
32. Cardarelli C O, Aksentijevich I, Pastan I, Gottesman M M. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res 1995; 55:1086-91.